SUBSCRIBE
SUBSCRIBE
News   Drug Development

Sanofi-Aventis (France), Vical Incorporated Limb Ischemia Drug NV1FGF Fails in Late-Stage Test

September 22, 2010 | 
1 min read
Sept. 22 (Bloomberg) -- Sanofi-Aventis SA said a drug that had showed promise in restoring blood vessel growth in damaged limbs was no better than a placebo in an advanced test.
Clinical research Phase 3 Europe
Sanofi
MORE ON THIS TOPIC
Blank paper notes attached by adhesive tape, white background, vector eps10 illustration
Deals
Ipsen sends clear Memo to rare diseases with up to $796M buyout
July 1, 2026
 · 
2 min read
 · 
Gabrielle Masson
Killer Whale, orcinus orca, Adult Leaping, Canada
Approvals
Orca opens up Treg cell therapy with FDA nod for allogeneic blood cancer treatment
July 1, 2026
 · 
2 min read
 · 
Heather McKenzie
Business and financial crisis vector concept with businessman falling down the hole. Symbol of market crash, recession, risk, bankruptcy and loss. Eps10 illustration.
Neuropsychiatric disorders
Vistagen in freefall as social anxiety drug fails Phase 3
July 1, 2026
 · 
2 min read
 · 
Tristan Manalac
Podcast
Sentiment at BIO soars as FDA resets, dealmaking evolves; Amgen’s Tavneos in hot water
July 1, 2026
 · 
2 min read
 · 
Jef Akst